新分子診斷的全球市場（2025-2029）

新分子診斷市場（2025-2029）

新型分子診斷市場預計從 2024 年到 2029 年擴大 38 億美元，預測期內複合年成長率為 6.4%。該報告包括對新分子診斷市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

該報告提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場是由慢性病的流行、全球老年人口的增加以及神經系統疾病的流行率上升所推動的。

該報告指出，與新型分子診斷相關的產品發布是未來幾年推動新型分子診斷市場成長的關鍵原因之一。此外，供應商之間的策略夥伴關係以及人工智慧和分子診斷的整合將帶來巨大的市場需求。

目錄

第1章執行摘要

• 市場概況

第2章 Technavio 分析

• 價格敏感度、生命週期、顧客購買籃子、採用率和購買標準分析
• 輸入和差異化因素的重要性
• 令人困惑的因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章市場規模評估

• 市場定義
• 細分市場分析
• 市場規模（2024年）
• 市場展望（2024-2029）

第5章 市場規模表現

• 新分子診斷的全球市場（2019-2023）
• 依技術分析（2019-2023）
• 最終用戶分析（2019-2023）
• 區域分析（2019-2023）
• 國家分析（2019-2023）

第6章定性分析

• 人工智慧對全球新興分子診斷市場的影響

第7章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章市場細分：依技術

• 細分市場
• 比較：按技術
• PCR：市場規模與預測（2024-2029）
• NGS：市場規模與預測（2024-2029）
• 微陣列技術：市場規模與預測（2024-2029）
• 其他：市場規模及預測（2024-2029）
• 市場機會：依技術分類

第 9 章 市場區隔：依最終用戶

• 細分市場
• 比較：按最終用戶
• 醫院/診所：市場規模與預測（2024-2029）
• 診斷實驗室：市場規模與預測（2024-2029）
• 其他：市場規模及預測（2024-2029）
• 市場機會：依最終用戶分類

第10章 客戶情況

• 客戶狀況概覽

第11章 地區情勢

• 區域分類
• 區域比較
• 北美：市場規模與預測（2024-2029）
• 歐洲：市場規模與預測（2024-2029）
• 亞洲：市場規模與預測（2024-2029）
• 世界其他地區：市場規模與預測（2024-2029）
• 美國：市場規模與預測（2024-2029）
• 中國：市場規模及預測（2024-2029）
• 英國：市場規模與預測（2024-2029）
• 德國：市場規模與預測（2024-2029）
• 日本：市場規模與預測（2024-2029）
• 印度：市場規模與預測（2024-2029）
• 加拿大：市場規模與預測（2024-2029）
• 韓國：市場規模與預測（2024-2029）
• 墨西哥：市場規模與預測（2024-2029）
• 澳洲：市場規模與預測（2024-2029）
• 市場機會：按地區

第12章 促進因素、挑戰、機會與限制因素

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機會與限制

第13章競爭格局

• 概述
• 競爭格局
• 混亂的情況
• 產業風險

第14章競爭分析

• 公司簡介
• 公司排名指數
• 公司市場定位
• Abbott Laboratories
• Agilent Technologies Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• BioMerieux SA
• Freenome Holdings Inc
• GRAIL Inc
• Hologic Inc.
• Invitae Corp.
• Natera Inc.
• OmniScience
• Paragonix Technologies Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Veracyte Inc.

第15章附錄

Emerging Molecular Diagnostics Market 2025-2029

The emerging molecular diagnostics market is forecasted to grow by USD 3.80 bn during 2024-2029, accelerating at a CAGR of 6.4% during the forecast period. The report on the emerging molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by prevalence of chronic diseases, increasing global geriatric population, and rising prevalence of neurological disorders.

Technavio's emerging molecular diagnostics market is segmented as below:

By Technology

• PCR
• NGS
• Microarray technologies
• Others

By End-user

• Hospitals and clinics
• Diagnostics laboratories
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the product launches associated with emerging molecular diagnostics as one of the prime reasons driving the emerging molecular diagnostics market growth during the next few years. Also, strategic partnerships between vendors and integration of ai with molecular diagnostics will lead to sizable demand in the market.

The report on the emerging molecular diagnostics market covers the following areas:

• Emerging Molecular Diagnostics Market sizing
• Emerging Molecular Diagnostics Market forecast
• Emerging Molecular Diagnostics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading emerging molecular diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, Danaher Corp., ELITechGroup SAS, F. Hoffmann La Roche Ltd., Freenome Holdings Inc, GRAIL Inc, Hologic Inc., Invitae Corp., Natera Inc., OmniScience, Paragonix Technologies Inc., Siemens Healthineers AG, Solone Life Sciences India Pvt. Ltd., Thermo Fisher Scientific Inc., U Gen Biotechnology Inc., and Veracyte Inc.. Also, the emerging molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Emerging Molecular Diagnostics Market 2019 - 2023
  • Historic Market Size - Data Table on Global Emerging Molecular Diagnostics Market 2019 - 2023 ($ billion)
• 5.2 Technology segment analysis 2019 - 2023
  • Historic Market Size - Technology Segment 2019 - 2023 ($ billion)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
• 5.5 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Emerging Molecular Diagnostics Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Technology

• 8.1 Market segments
  • Chart on Technology - Market share 2024-2029 (%)
  • Data Table on Technology - Market share 2024-2029 (%)
• 8.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
• 8.3 PCR - Market size and forecast 2024-2029
  • Chart on PCR - Market size and forecast 2024-2029 ($ billion)
  • Data Table on PCR - Market size and forecast 2024-2029 ($ billion)
  • Chart on PCR - Year-over-year growth 2024-2029 (%)
  • Data Table on PCR - Year-over-year growth 2024-2029 (%)
• 8.4 NGS - Market size and forecast 2024-2029
  • Chart on NGS - Market size and forecast 2024-2029 ($ billion)
  • Data Table on NGS - Market size and forecast 2024-2029 ($ billion)
  • Chart on NGS - Year-over-year growth 2024-2029 (%)
  • Data Table on NGS - Year-over-year growth 2024-2029 (%)
• 8.5 Microarray technologies - Market size and forecast 2024-2029
  • Chart on Microarray technologies - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Microarray technologies - Market size and forecast 2024-2029 ($ billion)
  • Chart on Microarray technologies - Year-over-year growth 2024-2029 (%)
  • Data Table on Microarray technologies - Year-over-year growth 2024-2029 (%)
• 8.6 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 8.7 Market opportunity by Technology
  • Market opportunity by Technology ($ billion)
  • Data Table on Market opportunity by Technology ($ billion)

9 Market Segmentation by End-user

• 9.1 Market segments
  • Chart on End-user - Market share 2024-2029 (%)
  • Data Table on End-user - Market share 2024-2029 (%)
• 9.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 9.3 Hospitals and clinics - Market size and forecast 2024-2029
  • Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
  • Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
• 9.4 Diagnostics laboratories - Market size and forecast 2024-2029
  • Chart on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion)
  • Chart on Diagnostics laboratories - Year-over-year growth 2024-2029 (%)
  • Data Table on Diagnostics laboratories - Year-over-year growth 2024-2029 (%)
• 9.5 Others - Market size and forecast 2024-2029
  • Chart on Others - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Others - Market size and forecast 2024-2029 ($ billion)
  • Chart on Others - Year-over-year growth 2024-2029 (%)
  • Data Table on Others - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ billion)
  • Data Table on Market opportunity by End-user ($ billion)

10 Customer Landscape

• 10.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

• 11.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 11.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 11.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ billion)
  • Data Table on North America - Market size and forecast 2024-2029 ($ billion)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 11.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 11.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 11.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ billion)
  • Data Table on US - Market size and forecast 2024-2029 ($ billion)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 11.8 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ billion)
  • Data Table on China - Market size and forecast 2024-2029 ($ billion)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 11.9 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ billion)
  • Data Table on UK - Market size and forecast 2024-2029 ($ billion)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 11.10 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 11.11 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 11.12 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ billion)
  • Data Table on India - Market size and forecast 2024-2029 ($ billion)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 11.13 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 11.14 South Korea - Market size and forecast 2024-2029
  • Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
  • Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
  • Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• 11.15 Mexico - Market size and forecast 2024-2029
  • Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
  • Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• 11.16 Australia - Market size and forecast 2024-2029
  • Chart on Australia - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
  • Chart on Australia - Year-over-year growth 2024-2029 (%)
  • Data Table on Australia - Year-over-year growth 2024-2029 (%)
• 11.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ billion)
  • Data Tables on Market opportunity By Geographical Landscape ($ billion)

12 Drivers, Challenges, and Opportunity/Restraints

• 12.1 Market drivers
• 12.2 Market challenges
• 12.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 12.4 Market opportunities/restraints

13 Competitive Landscape

• 13.1 Overview
• 13.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 13.3 Landscape disruption
  • Overview on factors of disruption
• 13.4 Industry risks
  • Impact of key risks on business

14 Competitive Analysis

• 14.1 Companies profiled
  • Companies covered
• 14.2 Company ranking index
  • Company ranking index
• 14.3 Market positioning of companies
  • Matrix on companies position and classification
• 14.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 14.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 14.6 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 14.7 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 14.8 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key news
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 14.9 Freenome Holdings Inc
  • Freenome Holdings Inc - Overview
  • Freenome Holdings Inc - Product / Service
  • Freenome Holdings Inc - Key offerings
  • SWOT
• 14.10 GRAIL Inc
  • GRAIL Inc - Overview
  • GRAIL Inc - Product / Service
  • GRAIL Inc - Key offerings
  • SWOT
• 14.11 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Business segments
  • Hologic Inc. - Key news
  • Hologic Inc. - Key offerings
  • Hologic Inc. - Segment focus
  • SWOT
• 14.12 Invitae Corp.
  • Invitae Corp. - Overview
  • Invitae Corp. - Product / Service
  • Invitae Corp. - Key offerings
  • SWOT
• 14.13 Natera Inc.
  • Natera Inc. - Overview
  • Natera Inc. - Product / Service
  • Natera Inc. - Key news
  • Natera Inc. - Key offerings
  • SWOT
• 14.14 OmniScience
  • OmniScience - Overview
  • OmniScience - Product / Service
  • OmniScience - Key offerings
  • SWOT
• 14.15 Paragonix Technologies Inc.
  • Paragonix Technologies Inc. - Overview
  • Paragonix Technologies Inc. - Product / Service
  • Paragonix Technologies Inc. - Key offerings
  • SWOT
• 14.16 Siemens Healthineers AG
  • Siemens Healthineers AG - Overview
  • Siemens Healthineers AG - Business segments
  • Siemens Healthineers AG - Key news
  • Siemens Healthineers AG - Key offerings
  • Siemens Healthineers AG - Segment focus
  • SWOT
• 14.17 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT
• 14.18 Veracyte Inc.
  • Veracyte Inc. - Overview
  • Veracyte Inc. - Product / Service
  • Veracyte Inc. - Key news
  • Veracyte Inc. - Key offerings
  • SWOT

15 Appendix

• 15.1 Scope of the report
• 15.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 15.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 15.4 Research methodology
  • Research methodology
• 15.5 Data procurement
  • Information sources
• 15.6 Data validation
  • Data validation
• 15.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 15.8 Data synthesis
  • Data synthesis
• 15.9 360 degree market analysis
  • 360 degree market analysis
• 15.10 List of abbreviations
  • List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits11: Overview on criticality of inputs and factors of differentiation
• Exhibits12: Overview on factors of disruption
• Exhibits13: Impact of drivers and challenges in 2024 and 2029
• Exhibits14: Parent Market
• Exhibits15: Data Table on - Parent Market
• Exhibits16: Market characteristics analysis
• Exhibits17: Value chain analysis
• Exhibits18: Offerings of companies included in the market definition
• Exhibits19: Market segments
• Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ billion)
• Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
• Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits24: Historic Market Size - Data Table on Global Emerging Molecular Diagnostics Market 2019 - 2023 ($ billion)
• Exhibits25: Historic Market Size - Technology Segment 2019 - 2023 ($ billion)
• Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
• Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
• Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
• Exhibits29: Five forces analysis - Comparison between 2024 and 2029
• Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
• Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
• Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
• Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
• Exhibits35: Chart on Market condition - Five forces 2024 and 2029
• Exhibits36: Chart on Technology - Market share 2024-2029 (%)
• Exhibits37: Data Table on Technology - Market share 2024-2029 (%)
• Exhibits38: Chart on Comparison by Technology
• Exhibits39: Data Table on Comparison by Technology
• Exhibits40: Chart on PCR - Market size and forecast 2024-2029 ($ billion)
• Exhibits41: Data Table on PCR - Market size and forecast 2024-2029 ($ billion)
• Exhibits42: Chart on PCR - Year-over-year growth 2024-2029 (%)
• Exhibits43: Data Table on PCR - Year-over-year growth 2024-2029 (%)
• Exhibits44: Chart on NGS - Market size and forecast 2024-2029 ($ billion)
• Exhibits45: Data Table on NGS - Market size and forecast 2024-2029 ($ billion)
• Exhibits46: Chart on NGS - Year-over-year growth 2024-2029 (%)
• Exhibits47: Data Table on NGS - Year-over-year growth 2024-2029 (%)
• Exhibits48: Chart on Microarray technologies - Market size and forecast 2024-2029 ($ billion)
• Exhibits49: Data Table on Microarray technologies - Market size and forecast 2024-2029 ($ billion)
• Exhibits50: Chart on Microarray technologies - Year-over-year growth 2024-2029 (%)
• Exhibits51: Data Table on Microarray technologies - Year-over-year growth 2024-2029 (%)
• Exhibits52: Chart on Others - Market size and forecast 2024-2029 ($ billion)
• Exhibits53: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
• Exhibits54: Chart on Others - Year-over-year growth 2024-2029 (%)
• Exhibits55: Data Table on Others - Year-over-year growth 2024-2029 (%)
• Exhibits56: Market opportunity by Technology ($ billion)
• Exhibits57: Data Table on Market opportunity by Technology ($ billion)
• Exhibits58: Chart on End-user - Market share 2024-2029 (%)
• Exhibits59: Data Table on End-user - Market share 2024-2029 (%)
• Exhibits60: Chart on Comparison by End-user
• Exhibits61: Data Table on Comparison by End-user
• Exhibits62: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
• Exhibits63: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ billion)
• Exhibits64: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
• Exhibits65: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
• Exhibits66: Chart on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion)
• Exhibits67: Data Table on Diagnostics laboratories - Market size and forecast 2024-2029 ($ billion)
• Exhibits68: Chart on Diagnostics laboratories - Year-over-year growth 2024-2029 (%)
• Exhibits69: Data Table on Diagnostics laboratories - Year-over-year growth 2024-2029 (%)
• Exhibits70: Chart on Others - Market size and forecast 2024-2029 ($ billion)
• Exhibits71: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
• Exhibits72: Chart on Others - Year-over-year growth 2024-2029 (%)
• Exhibits73: Data Table on Others - Year-over-year growth 2024-2029 (%)
• Exhibits74: Market opportunity by End-user ($ billion)
• Exhibits75: Data Table on Market opportunity by End-user ($ billion)
• Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits77: Chart on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits78: Data Table on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits79: Chart on Geographic comparison
• Exhibits80: Data Table on Geographic comparison
• Exhibits81: Chart on North America - Market size and forecast 2024-2029 ($ billion)
• Exhibits82: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
• Exhibits83: Chart on North America - Year-over-year growth 2024-2029 (%)
• Exhibits84: Data Table on North America - Year-over-year growth 2024-2029 (%)
• Exhibits85: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
• Exhibits86: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
• Exhibits87: Chart on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits88: Data Table on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits89: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
• Exhibits90: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
• Exhibits91: Chart on Asia - Year-over-year growth 2024-2029 (%)
• Exhibits92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
• Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
• Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
• Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• Exhibits97: Chart on US - Market size and forecast 2024-2029 ($ billion)
• Exhibits98: Data Table on US - Market size and forecast 2024-2029 ($ billion)
• Exhibits99: Chart on US - Year-over-year growth 2024-2029 (%)
• Exhibits100: Data Table on US - Year-over-year growth 2024-2029 (%)
• Exhibits101: Chart on China - Market size and forecast 2024-2029 ($ billion)
• Exhibits102: Data Table on China - Market size and forecast 2024-2029 ($ billion)
• Exhibits103: Chart on China - Year-over-year growth 2024-2029 (%)
• Exhibits104: Data Table on China - Year-over-year growth 2024-2029 (%)
• Exhibits105: Chart on UK - Market size and forecast 2024-2029 ($ billion)
• Exhibits106: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
• Exhibits107: Chart on UK - Year-over-year growth 2024-2029 (%)
• Exhibits108: Data Table on UK - Year-over-year growth 2024-2029 (%)
• Exhibits109: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
• Exhibits110: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
• Exhibits111: Chart on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits112: Data Table on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits113: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
• Exhibits114: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
• Exhibits115: Chart on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits116: Data Table on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits117: Chart on India - Market size and forecast 2024-2029 ($ billion)
• Exhibits118: Data Table on India - Market size and forecast 2024-2029 ($ billion)
• Exhibits119: Chart on India - Year-over-year growth 2024-2029 (%)
• Exhibits120: Data Table on India - Year-over-year growth 2024-2029 (%)
• Exhibits121: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
• Exhibits122: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
• Exhibits123: Chart on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits124: Data Table on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits125: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
• Exhibits126: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
• Exhibits127: Chart on South Korea - Year-over-year growth 2024-2029 (%)
• Exhibits128: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
• Exhibits129: Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
• Exhibits130: Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
• Exhibits131: Chart on Mexico - Year-over-year growth 2024-2029 (%)
• Exhibits132: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• Exhibits133: Chart on Australia - Market size and forecast 2024-2029 ($ billion)
• Exhibits134: Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
• Exhibits135: Chart on Australia - Year-over-year growth 2024-2029 (%)
• Exhibits136: Data Table on Australia - Year-over-year growth 2024-2029 (%)
• Exhibits137: Market opportunity By Geographical Landscape ($ billion)
• Exhibits138: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits139: Impact of drivers and challenges in 2024 and 2029
• Exhibits140: Overview on criticality of inputs and factors of differentiation
• Exhibits141: Overview on factors of disruption
• Exhibits142: Impact of key risks on business
• Exhibits143: Companies covered
• Exhibits144: Company ranking index
• Exhibits145: Matrix on companies position and classification
• Exhibits146: Abbott Laboratories - Overview
• Exhibits147: Abbott Laboratories - Business segments
• Exhibits148: Abbott Laboratories - Key news
• Exhibits149: Abbott Laboratories - Key offerings
• Exhibits150: Abbott Laboratories - Segment focus
• Exhibits151: SWOT
• Exhibits152: Agilent Technologies Inc. - Overview
• Exhibits153: Agilent Technologies Inc. - Business segments
• Exhibits154: Agilent Technologies Inc. - Key news
• Exhibits155: Agilent Technologies Inc. - Key offerings
• Exhibits156: Agilent Technologies Inc. - Segment focus
• Exhibits157: SWOT
• Exhibits158: Becton Dickinson and Co. - Overview
• Exhibits159: Becton Dickinson and Co. - Business segments
• Exhibits160: Becton Dickinson and Co. - Key news
• Exhibits161: Becton Dickinson and Co. - Key offerings
• Exhibits162: Becton Dickinson and Co. - Segment focus
• Exhibits163: SWOT
• Exhibits164: Bio Rad Laboratories Inc. - Overview
• Exhibits165: Bio Rad Laboratories Inc. - Business segments
• Exhibits166: Bio Rad Laboratories Inc. - Key news
• Exhibits167: Bio Rad Laboratories Inc. - Key offerings
• Exhibits168: Bio Rad Laboratories Inc. - Segment focus
• Exhibits169: SWOT
• Exhibits170: BioMerieux SA - Overview
• Exhibits171: BioMerieux SA - Business segments
• Exhibits172: BioMerieux SA - Key news
• Exhibits173: BioMerieux SA - Key offerings
• Exhibits174: BioMerieux SA - Segment focus
• Exhibits175: SWOT
• Exhibits176: Freenome Holdings Inc - Overview
• Exhibits177: Freenome Holdings Inc - Product / Service
• Exhibits178: Freenome Holdings Inc - Key offerings
• Exhibits179: SWOT
• Exhibits180: GRAIL Inc - Overview
• Exhibits181: GRAIL Inc - Product / Service
• Exhibits182: GRAIL Inc - Key offerings
• Exhibits183: SWOT
• Exhibits184: Hologic Inc. - Overview
• Exhibits185: Hologic Inc. - Business segments
• Exhibits186: Hologic Inc. - Key news
• Exhibits187: Hologic Inc. - Key offerings
• Exhibits188: Hologic Inc. - Segment focus
• Exhibits189: SWOT
• Exhibits190: Invitae Corp. - Overview
• Exhibits191: Invitae Corp. - Product / Service
• Exhibits192: Invitae Corp. - Key offerings
• Exhibits193: SWOT
• Exhibits194: Natera Inc. - Overview
• Exhibits195: Natera Inc. - Product / Service
• Exhibits196: Natera Inc. - Key news
• Exhibits197: Natera Inc. - Key offerings
• Exhibits198: SWOT
• Exhibits199: OmniScience - Overview
• Exhibits200: OmniScience - Product / Service
• Exhibits201: OmniScience - Key offerings
• Exhibits202: SWOT
• Exhibits203: Paragonix Technologies Inc. - Overview
• Exhibits204: Paragonix Technologies Inc. - Product / Service
• Exhibits205: Paragonix Technologies Inc. - Key offerings
• Exhibits206: SWOT
• Exhibits207: Siemens Healthineers AG - Overview
• Exhibits208: Siemens Healthineers AG - Business segments
• Exhibits209: Siemens Healthineers AG - Key news
• Exhibits210: Siemens Healthineers AG - Key offerings
• Exhibits211: Siemens Healthineers AG - Segment focus
• Exhibits212: SWOT
• Exhibits213: Thermo Fisher Scientific Inc. - Overview
• Exhibits214: Thermo Fisher Scientific Inc. - Business segments
• Exhibits215: Thermo Fisher Scientific Inc. - Key news
• Exhibits216: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits217: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits218: SWOT
• Exhibits219: Veracyte Inc. - Overview
• Exhibits220: Veracyte Inc. - Product / Service
• Exhibits221: Veracyte Inc. - Key news
• Exhibits222: Veracyte Inc. - Key offerings
• Exhibits223: SWOT
• Exhibits224: Inclusions checklist
• Exhibits225: Exclusions checklist
• Exhibits226: Currency conversion rates for US$
• Exhibits227: Research methodology
• Exhibits228: Information sources
• Exhibits229: Data validation
• Exhibits230: Validation techniques employed for market sizing
• Exhibits231: Data synthesis
• Exhibits232: 360 degree market analysis
• Exhibits233: List of abbreviations